Cargando…
High-throughput screening of clinically approved drugs that prime nonviral gene delivery to human Mesenchymal stem cells
BACKGROUND: Human mesenchymal stem cells (hMSCs) are intensely researched for applications in cell therapeutics due to their unique properties, however, intrinsic therapeutic properties of hMSCs could be enhanced by genetic modification. Viral transduction is efficient, but suffers from safety issue...
Autores principales: | Kozisek, Tyler, Hamann, Andrew, Nguyen, Albert, Miller, Michael, Plautz, Sarah, Pannier, Angela K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238544/ https://www.ncbi.nlm.nih.gov/pubmed/32467728 http://dx.doi.org/10.1186/s13036-020-00238-1 |
Ejemplares similares
-
Mechanisms of unprimed and dexamethasone‐primed nonviral gene delivery to human mesenchymal stem cells
por: Hamann, Andrew, et al.
Publicado: (2018) -
Glucocorticoid Priming of Nonviral Gene Delivery to hMSCs Increases Transfection by Reducing Induced Stresses
por: Hamann, Andrew, et al.
Publicado: (2020) -
Nucleic acid delivery to mesenchymal stem cells: a review of nonviral methods and applications
por: Hamann, Andrew, et al.
Publicado: (2019) -
High‐throughput screening of clinically approved drugs that prime polyethylenimine transfection reveals modulation of mitochondria dysfunction response improves gene transfer efficiencies
por: Nguyen, Albert, et al.
Publicado: (2016) -
The role of surface chemistry-induced cell characteristics on nonviral gene delivery to mouse fibroblasts
por: Kasputis, Tadas, et al.
Publicado: (2012)